
<http://bio2rdf.org/drugbank:DB00036> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Coagulation factor VIIa" ;
	<http://schema.org/description> "Recombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade.1 NovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form." ;
	<http://schema.org/url> "https://www.drugbank.ca/drugs/DB00036" ;
	<http://schema.org/doseSchedule> "Kit form with  route" ;
	<http://schema.org/legalStatus> "approved" ;
	<http://schema.org/mechanismOfAction> "NovoSeven activates the coagulation or clotting cascade by cleaving Factor IX and Factor X, which activates them and then leads to activation of thrombin and fibrin." ;
	<http://schema.org/alternateName> "Coagulation factor VII precursor" ;
	<http://schema.org/sameAs> "https://www.drugbank.ca/drugs/DB00036" .
